Min-Sung joined Carlsquare in 2024 as an Industry Advisor for Venture Capital and Digital Health based in Berlin. Since 2013, he invested in successful Digital Health companies such as mySugr (exited to ROCHE) and Amwell (IPO 2020). Previously, he was responsible for the Berlin office of Samsung Catalyst Fund and helped create AllianzX (USD 3.0 bn AUM). Min-Sung studied at Witten/Herdecke, Harvard, St. Gallen, and in Seoul.